[Disseminated cryptococcosis as inaugural manifestation of AIDS].
Disseminated cryptococcal disease is typically seen in patients with HIV infection. We report here the evolution of a patient with disseminated cryptococcosis whose treatment failed after ten weeks of induction therapy with amphotericin B. This case illustrates the importance of careful initial evaluation, and close clinical follow-up of these patients who are at risk of developing other opportunistic infections and drug-related complications.
Fournier
Y
Y
Service de médecine B, Institut de pathologie, CHUV, Lausanne. Yvan.Fournier@hospvd.ch
Bellini
C
C
Baur
A S
AS
Waeber
G
G
Cavassini
M
M
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001706:Biopsy; D003453:Cryptococcosis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D003455:Cryptococcus neoformans / Q000648:ultrastructure; D003881:Dermatomycoses / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000175:diagnosis*; D006801:Humans; D012867:Skin / Q000473:pathology
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole